Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Search
  1. OncologyPRO
  2. Meeting resources

ESMO Breast Cancer Virtual Meeting 2020

23 - 24 May 2020

Virtual Meeting

ESMO-Breast-Cancer-Virtual-Meeting-1000x1000

Abstracts and ePosters are open access. Presentations and webcasts from ESMO Breast Cancer 2020 are restricted to ESMO members according to the presenters' agreement to release them.

Browse the abstracts book

The use of these presentations is for personal educational purposes only. ESMO thanks the authors for their generosity.

Meeting programme Next/upcoming meetings

ESMO Breast Cancer Virtual Meeting is a congress designed for breast cancer researchers and clinicians who have a specific interest in innovation (including translational research, new agents, molecular and functional diagnostics, biomarkers and cutting-edge research applications in the clinical setting) and care.

Industry Sponsored Satellite Symposia (Open access)

Expert Video Report on Novel Drugs for HER2+ Advanced Breast Cancer: Focus on Brain Metastases

Special sessions in open access

Hide
Filter by:
Search:
Reset

There are 327 resources available

Introduction

Presenter: Joseph Gligorov

Session: Eisai - Industry Satellite Symposium: In the modern management of HER2-/HR+ MBC, should chemotherapy be the treatment of last resort?

Resources:

Webcast

Against the Motion – Opening Remarks

Presenter: Javier Cortés

Session: Eisai - Industry Satellite Symposium: In the modern management of HER2-/HR+ MBC, should chemotherapy be the treatment of last resort?

Resources:

Webcast

For the Motion – Closing Remarks

Presenter: Peter Schmid

Session: Eisai - Industry Satellite Symposium: In the modern management of HER2-/HR+ MBC, should chemotherapy be the treatment of last resort?

Resources:

Webcast

For the Motion – Opening Remarks

Presenter: Peter Schmid

Session: Eisai - Industry Satellite Symposium: In the modern management of HER2-/HR+ MBC, should chemotherapy be the treatment of last resort?

Resources:

Webcast

Against the Motion – Closing Remarks

Presenter: Javier Cortés

Session: Eisai - Industry Satellite Symposium: In the modern management of HER2-/HR+ MBC, should chemotherapy be the treatment of last resort?

Resources:

Webcast

Close (Thank you)

Presenter: Joseph Gligorov

Session: Eisai - Industry Satellite Symposium: In the modern management of HER2-/HR+ MBC, should chemotherapy be the treatment of last resort?

Resources:

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings